Estimate Recalculated Apr 9, 2025 10:32PM EST
JP MORGAN PARTNERS BHCA LP has an estimated net worth of $2.24 Billion. This is based on reported shares across multiple companies, which include CORGENTECH INC, SANTARUS INC, 1 800 FLOWERS COM INC, HOME PRODUCTS INTERNATIONAL INC, COMSCORE, INC., ICAGEN INC, MYOGEN INC, SEATTLE GENETICS INC /WA, PHARMOS CORP, EYETECH PHARMACEUTICALS INC, BARRIER THERAPEUTICS INC, PortalPlayer, Inc., JP MORGAN PARTNERS BHCA LP, BILL BARRETT CORP, CMGI INC, WARNER CHILCOTT PLC, NUCO2 INC /FL, ENCORE ACQUISITION CO, ARAMARK Holdings Corp, Emergent BioSolutions Inc., HANGER ORTHOPEDIC GROUP INC, Kraton Performance Polymers, Inc., Warner Chilcott Ltd, CANDLEWOOD HOTEL CO INC, ARAMARK CORP, ARAMARK CORP/DE, PLIANT CORP, CROWN MEDIA HOLDINGS INC, and GUITAR CENTER INC.
JP MORGAN PARTNERS BHCA LP's CIK is 0001106607
2004 was JP MORGAN PARTNERS BHCA LP's most active year for acquiring shares with 28 total transactions. JP MORGAN PARTNERS BHCA LP's most active month to acquire stocks was the month of July. 2004 was JP MORGAN PARTNERS BHCA LP's most active year for disposing of shares, totalling 71 transactions. JP MORGAN PARTNERS BHCA LP's most active month to dispose stocks was the month of July. 2004 saw JP MORGAN PARTNERS BHCA LP paying a total of $8,333,324.00 for 17,521,508 shares, this is the most they've acquired in one year. In 2015 JP MORGAN PARTNERS BHCA LP cashed out on 26,532,756 shares for a total of $824,329,338.96, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!